Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Net Income (2016 - 2025)

Historic Net Income for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Novartis Ag's Net Income fell 203.96% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.4 billion, marking a year-over-year increase of 1988.27%. This contributed to the annual value of $14.0 billion for FY2025, which is 1698.63% up from last year.
  • Latest data reveals that Novartis Ag reported Net Income of $3.2 billion as of Q4 2025, which was down 203.96% from $4.2 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Net Income peaked at $17.0 billion during Q4 2021, and registered a low of $46.0 million during Q2 2023.
  • For the 5-year period, Novartis Ag's Net Income averaged around $3.4 billion, with its median value being $3.2 billion (2021).
  • Per our database at Business Quant, Novartis Ag's Net Income crashed by 9910.92% in 2022 and then surged by 825000.0% in 2024.
  • Over the past 5 years, Novartis Ag's Net Income (Quarter) stood at $17.0 billion in 2021, then crashed by 99.11% to $151.0 million in 2022, then soared by 3768.87% to $5.8 billion in 2023, then crashed by 43.77% to $3.3 billion in 2024, then fell by 2.04% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q4 2025, $4.2 billion for Q3 2025, and $4.5 billion during Q2 2025.